The connection between neonatal jaundice and neurodevelopment later in life: a national birth cohort study Authors: Won Seok Lee, Ju Hee Kim, Boeun Han, Jeewon Shin, Eunkyo Ha, Eun Lee, Ji Hee Kwak, Seonkyeong Rhie, Man Yong Han Published: 2026 ABSTRACT BackgroundElevated serum bilirubin in neonates may serve as an early indicator of later neurodevelopment after birth. This study examined the connection between neonatal jaundice requiring phototherapy and later neurodevelopment.MethodsThis retrospective population-based cohort included 3,203,983 children born in Korea from 2009 to 2015, tracked from birth until December 2021 in Korea. Neurodevelopmental outcomes at 66–71 months of age were assessed using national child health screening data. Analyses controlled for confounders including sex, birth weight, prematurity, chromosomal abnormalities, congenital malformations, income, and infant feeding type. Neurodevelopmental outcomes were evaluated in six domains (gross motor, fine motor, cognition, language, social skills, and self-help) using the Korean Developmental Screening Test (K-DST). Effect of phototherapy duration on each domain was also examined.ResultsA total of 1,004,385 neonates were included, of whom 121,366 (56.0% male) received phototherapy. Neonatal jaundice requiring phototherapy was significantly associated with abnormal outcomes in gross motor (adjusted odds ratio [aOR] 1.087, 95% CI 1.049–1.127, P < 0.0001), cognition (aOR 1.045, 95% CI 1.013–1.077, P = 0.0052), and language (aOR 1.049, 95% CI 1.013–1.086, P = 0.0072). Longer phototherapy duration (≥ 5 days) was associated with abnormal outcomes in overall assessment and gross motor, fine motor, cognition, and language domains.ConclusionsNeonatal jaundice requiring phototherapy was associated with higher risk of abnormal neurodevelopment at age six, particularly in gross motor, cognition, and language domains. Prolonged phototherapy was also linked to adverse outcomes.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12889-026-28051-3. Introduction Neonatal jaundice is a common problem in the first week of the neonatal period, which can be a physiologic phenomenon or a sign of a pathological disease [1]. The majority of neonatal jaundice cases is successfully managed with phototherapy [1] and usually resolves without complications, although there is potential for neurotoxicity in both preterm and term infants [2]. Elevated levels of bilirubin in neonates have long been associated with adverse developmental outcomes such as cerebral palsy [3], neurocognitive impairment [4], language processing disorders [5], and deafness [6]. Therefore, in cases of severe neonatal jaundice, aggressive treatment to lower bilirubin levels is often provided in the neonatal intensive care units (NICU). Despite these efforts, numerous studies have consistently linked jaundice itself with various childhood diseases. A recent systematic review reported an association between neonatal jaundice and an increased risk of certain childhood-onset psychiatric disease, such as autism spectrum disorder (ASD) and attention deficit-hyperactivity disorder (ADHD) [7]. However, reports on the specific associations between neonatal jaundice and various neurodevelopmental domains in children have been limited. Previous studies have largely focused on a restricted range of diseases [3, 4, 8]. and have given insufficient consideration to factors such as breastfeeding [9], prematurity, birth weight [10], and the severity and treatment of neonatal jaundice [11]. Therefore, our goal is to assess the connections between neonatal jaundice requiring phototherapy and neurodevelopment in later life, consisted of six domains (gross motor, fine motor, cognition, language, social skills, and self-help) using the standardized Korean Developmental Screening Test (K-DST) at the age of six. We also aimed to determine how the duration of phototherapy affects the outcomes in each of these neurodevelopmental domains. Additionally, we used large-scale national data while controlling for various confounding factors that could influence neurodevelopment in childhood, such as sex, birth weight, prematurity, chromosomal abnormalities, congenital malformations, familial income levels, and infant feeding types. Methods Study design and data sources This study used an administrative observational cohort design based on data from the National Health Insurance Service (NHIS) database, which was linked to the National Health Screening Program for Infants and Children (NHSPIC). The NHSPIC conducts seven rounds of health screening to assess nutrition, neurodevelopment, and physical growth in children aged 4 to 71 months [12–14]. The NHIS is a mandatory national health insurance system that covers nearly 98% of the Korean population and provides demographic and clinical characteristics (sex, region at birth, familial income levels, calendar year at birth, and disease information). Additional baseline characteristics, including birth weight, prematurity, past history of care in the neonatal intensive care units (NICU), chromosomal abnormalities, congenital malformations, region at birth, familial income quantiles, calender years at birth, and infant feeding type from first round, were also included. Neurodevepmental outcomes were assessed in six domains (gross motor, fine motor, cognition, language, social skills, and self-help) in seventh round of NHSPIC at the age of 66 to 71 months. The Institutional Review Board of the Hallym University Kangnam Sacred Heart Hospital (2021-08-006) approved the study protocol, and informed consent was waived as the data were anonymized. Study population and exposure This population-based cohort study involved all children (N = 3,203,983) born between 2009 and 2015 in Korea and tracked from birth to December 2021. Among them, we included children with data on birth weight, infant feeding type, and neurodevelopmental screening results from the Korean Developmental Screening Test (K-DST) of the seventh NHSPIC at age of 66 to 71 months. Among the total eligible participants (n = 2,099,162), the jaundice group (n = 728,863) was defined as children with diagnosis of neonatal jaundice under international classification of diseases (ICD)-10 code of P59, while the remaining participants constituted the control group (n = 1,370,299). We identified the ICD-10 based diagnosis of neonatal jaundice, among whom 728,863 (25.0%) having jaundice and 182,509 had undergone phototherapy (EDI code MM350). In the control group, we excluded children who had received phototherapy (n = 13,048). Although these participants did not have a registered ICD-10 code for P59, phototherapy procedure codes were identified in the claims database; therefore, they were excluded to minimize potential exposure misclassification. Additionally, the jaundice group was further stratified into three subgroups based on the phototherapy duration for neonatal jaundice, as classified under ICD-10 code P59: the first quartile (< 25th percentile), the interquartile range (IQR) (25th – 75th percentile), and fourth quartile (≥ 75th percentile). The number and proportion of participants in each subgroup was presented in Supplementary eTable 1. Furthermore, we included children from both control and jaundice groups who had available data on infant feeding type from the 1st NHSPIC at the age of 4 to 6 months and neurodevelopmental outcomes from the 7th NHSPIC at the age of 66 to 71 months. After applying these criteria, the final sample consisted of 121,366 children in jaundice group, and 883,019 in the control group. (Fig. 1). Fig. 1Study flow Study flow Main outcomes — neurodevelopment and neonatal jaundice The main outcomes of this study were the results of neurodevelopmental screening results at 66 to 71 months of age using the Korean Developmental Screening Test for Infants and Children (K-DST). The K-DST, validated developmental screening tool and detailed in Supplementary eTable 2 [12–14], was developed by pediatrican, pediatric rehabilitation and pediatric psychiatrist for children under 7 years of age. It is a parent-reported questionnaire covering [15] six subdomains: gross motor, fine motor, cognition, language, social skills, and self-help, with each subdomain consisting of eight questions rated from 0 to 3. The outcomes were categorized into four classifications: ‘advanced development’ (scores ≥ 1 standard deviation (SD) above the mean), ‘age appropriate’ (scores within the range of 1 SD below to < 1 SD above the mean), ‘follow-up requests’ (scores from 2 SDs below to < 1 SD below the mean), and ‘recommendation for further evaluation’ (scores < 2 SDs below the mean), as detailed in Supplementary eTable 3. The K-DST classification system is based on standardized normative distributions established during national validation studies and was not derived from the distribution of the present study cohort. The outcome of interest was the recommendation for further evaluation, considered an abnormal finding. The overall assessment classified as abnormal if any subdomains indicated the need for further evaluation, facilitating targeted interventions based on developmental status. Additional outcomes — neurodevelopment and neonatal jaundice, stratified by phototherapy duration The connection between neonatal jaundice and the abnormal K-DST results in the NHISC at age of 66 to 71 months, stratified by phototherapy duration, was also investigated. Children of neonatal jaundice requiring phototherapy were stratified into three subgroups base on the phototherapy duration: the first quartile (< 25th percentile), the interquartile range (IQR) (25th – 75th percentile), and fourth quartile (≥ 75th percentile). Phototherapy duration was calculated in days using insurance claim records. Covariate The baseline demographic and clinical variables were obtained from the NHIS and NHSPIC databases. Information on sex (boy, or girl), low birth weight (< 2.5 kg, or ≥ 2.5 kg) prematurity (gestational periods < 37 weeks), calendar year at birth (2009 to 2011, or 2012 to 2015), infant feeding type (exclusive breast feeding, or mixed and artificial feeding) and the age of neurodevepmental status in national health screening was obtained from the NHSPIC. Calendar year of birth was included as a covariate to account for temporal changes in neonatal care practices, phototherapy utilization, and developmental screening patterns during the study period. Information of infant feeding type was also obtained from the 1st NHSPIC database using a parent-answered questionnaire at 4 to 6 months of age. The question included “What do you feed your child usually?” The answers were as follows: breastfeeding alone, formula alone, mixed feeding with breastfeeding and formula, and specialized formula. Additionally, past history of care in the neonatal intensive care unit (NICU), chromosomal abnormalities (ICD-10 code of Q90 - Q99), congenital malformations (ICD-10 code of Q00 - Q89), region at birth (Seoul and metropolitan, or city and rural), familial income quantile for economic status (< 25, ≥ 25 and < 75, ≥ 75 percentile), was obtained from the NHIS. Baseline covariates are shown in Supplementary eTable 4. Statistical analysis All individuals were followed up from birth until the first diagnosis of the disease, death, or the end of the study (December 31, 2021). A multiple imputation procedure was used to deal with missing data. In addition, we utilized covariate adjustment methods for controlling covariates to confirm the association between neonatal jaundice and and neurodevelopment. First, to analyze the connection between neonatal jaundice and neurodevelopmental abnormality at age of 66–71 months, crue and adjusted odd ratios (OR) and 95% confidence interval (CI) were calculated. All analyses were adjusted for sex, birth weight, prematurity, past history of care in the NICU, chromosomal abnormalities, congenital malformations, region at birth, familial income quantiles, calender years at birth, and infant feeding type. Forest plots with 95% confidential interval were generated to illustrate the association between neonatal jaundice and abnormal neurodevelopmental outcome in national health screening, stratified by phototherapy duration. P values of less than 0.05 were considered statistically significant. All statistical analyses were conducted using the SAS Enterprise Guide version, 7.1 (SAS Institute Inc.). Results Baseline characteristics of the study subjects The primary analysis emcompassed 1,004,385 participants, divided into unexposed neonate (n = 883,019) and jaundice neonate (n = 121,366). Among unexposed neonates, 439,812 (49.81%) were boys, whereas 67,927 (55.97%) of neonates with jaundice were boys. In the unexposed group, low birth weight (< 2.5 kg) was observed in 26,899 (3.05%), compared to 19,940 (16.43%) neonates in the jaundice group. A history of prematurity was reported in 27,186 (3.08%) in the unexposed group and 24,924 (20.54%) in the jaundice group. Data on chromosomal abnormalities and congenital malformations were obtained from the NHIS database, and identified using ICD-10 codes Q90-99 and Q00-89, respectively. Chromosomal abnormalities were observed in 2,045 (0.23%) in the unexposed group and 631 (0.52%) in the jaundice group. Congenital malformations were present in 179,628 (20.34%) in the unexposed group and 34,539 (28.46%) in the jaundice group. (Table 1). Table 1Demographic and clinical characteristics of the participantsCharacteriscticsParticipants (N = 1,004,385)P valueControl group(n = 883,019)Jaundice group(n = 121,366)Sex a< 0.0001 Boy439,812 (49.81%)67,927 (55.97%) Girl443,207 (50.19%)53,439 (44.03%)Birth weight a< 0.0001 ≥ 2.5 kg856,120 (96.95%)101,426 (83.57%) < 2.5 kg26,899 (3.05%)19,940 (16.43%)Prematurity a27,186 (3.08%)24,924 (20.54%)< 0.0001Past history of care in the NICU b14,684 (1.66%)29,572 (24.37%)< 0.0001Chromosomal abnormalities b, c2,045 (0.23%)631 (0.52%)< 0.0001Congenital malformations b, d179,628 (20.34%)34,539 (28.46%)< 0.0001Region at birth b, e< 0.0001 Seoul, or metropolitan390,066 (44.17%)51,156 (42.15%) City, or rural485,368 (54.97%)69,304 (57.10%)Familial income quantiles b, f< 0.0001 Low (< 25 percentile)212,718 (24.09%)29,208 (24.07%) Intermediate (≥ 25, < 75 percentile)425,529 (48.19%)58,424 (48.14%) High (> 75 percentile)212,749 (24.09%)29,208 (24.07%)Calender years at birth a< 0.0001 2009–2011285,623 (32.53%)37,839 (31.18%) 2012–2015597,396 (67.65%)83,527 (68.82%)Infant feeding type a, g< 0.0001 Exclusive breast feeding333,198 (37.73%)42,215 (34.78%) Mixed feeding366,981 (41.56%)54,863 (45.20%) Artificial milk182,840 (20.71%)24,288 (20.01%)Age of neurodevelopmental status in NHSPIC(mean; month, SD) a69.334 (2.049)69.434 (2.061)Abbreviations; n Number, SD Standard deviation, NHSPIC National Health Screening Program for Infants and Children, NICU Neonate intensive care unita Obtained from the NHSPICb Obtained from the National Health Insurance Service (NHIS)c The medical histories of chromosomal abnormalities were obtained in data of the NHIS as ICD-10 code of Q90-Q99d The medical histories of congenital malformations were obtained in data of the NHIS as ICD-10 code of Q00-Q89e Missing data: control group = 7,585 (0.86%), jaundice group = 906 (0.75%)f Economic status was determined by the amount of insurance copayment, which directly reflects family income, missing data: control group = 32,023 (3.63%), jaundice group = 4,526 (3.73%)g Missing data : control group = 0 (0.0%), jaundice group = 0 (0.0%) Table 1Demographic and clinical characteristics of the participantsCharacteriscticsParticipants (N = 1,004,385)P valueControl group(n = 883,019)Jaundice group(n = 121,366)Sex a< 0.0001 Boy439,812 (49.81%)67,927 (55.97%) Girl443,207 (50.19%)53,439 (44.03%)Birth weight a< 0.0001 ≥ 2.5 kg856,120 (96.95%)101,426 (83.57%) < 2.5 kg26,899 (3.05%)19,940 (16.43%)Prematurity a27,186 (3.08%)24,924 (20.54%)< 0.0001Past history of care in the NICU b14,684 (1.66%)29,572 (24.37%)< 0.0001Chromosomal abnormalities b, c2,045 (0.23%)631 (0.52%)< 0.0001Congenital malformations b, d179,628 (20.34%)34,539 (28.46%)< 0.0001Region at birth b, e< 0.0001 Seoul, or metropolitan390,066 (44.17%)51,156 (42.15%) City, or rural485,368 (54.97%)69,304 (57.10%)Familial income quantiles b, f< 0.0001 Low (< 25 percentile)212,718 (24.09%)29,208 (24.07%) Intermediate (≥ 25, < 75 percentile)425,529 (48.19%)58,424 (48.14%) High (> 75 percentile)212,749 (24.09%)29,208 (24.07%)Calender years at birth a< 0.0001 2009–2011285,623 (32.53%)37,839 (31.18%) 2012–2015597,396 (67.65%)83,527 (68.82%)Infant feeding type a, g< 0.0001 Exclusive breast feeding333,198 (37.73%)42,215 (34.78%) Mixed feeding366,981 (41.56%)54,863 (45.20%) Artificial milk182,840 (20.71%)24,288 (20.01%)Age of neurodevelopmental status in NHSPIC(mean; month, SD) a69.334 (2.049)69.434 (2.061)Abbreviations; n Number, SD Standard deviation, NHSPIC National Health Screening Program for Infants and Children, NICU Neonate intensive care unita Obtained from the NHSPICb Obtained from the National Health Insurance Service (NHIS)c The medical histories of chromosomal abnormalities were obtained in data of the NHIS as ICD-10 code of Q90-Q99d The medical histories of congenital malformations were obtained in data of the NHIS as ICD-10 code of Q00-Q89e Missing data: control group = 7,585 (0.86%), jaundice group = 906 (0.75%)f Economic status was determined by the amount of insurance copayment, which directly reflects family income, missing data: control group = 32,023 (3.63%), jaundice group = 4,526 (3.73%)g Missing data : control group = 0 (0.0%), jaundice group = 0 (0.0%) Demographic and clinical characteristics of the participants Age of neurodevelopmental status in NHSPIC (mean; month, SD) a Abbreviations; n Number, SD Standard deviation, NHSPIC National Health Screening Program for Infants and Children, NICU Neonate intensive care unit a Obtained from the NHSPIC b Obtained from the National Health Insurance Service (NHIS) c The medical histories of chromosomal abnormalities were obtained in data of the NHIS as ICD-10 code of Q90-Q99 d The medical histories of congenital malformations were obtained in data of the NHIS as ICD-10 code of Q00-Q89 e Missing data: control group = 7,585 (0.86%), jaundice group = 906 (0.75%) f Economic status was determined by the amount of insurance copayment, which directly reflects family income, missing data: control group = 32,023 (3.63%), jaundice group = 4,526 (3.73%) g Missing data : control group = 0 (0.0%), jaundice group = 0 (0.0%) Neurodevelopment and neonatal jaundice Table 2 presents the association between neonatal jaundice requiring phototherapy and the abnormal K-DST results in the neurodevelopmental screening at 66–71 months of age. We identified that exposed cohort was significantly associated with abnormal neurodevelopmental screening results in the domains of gross motor (adjusted odd ratio [aOR] 1.087, 95% confidential interval [CI] 1.049–1.127, P < 0.0001), cognition (aOR 1.045, 95% CI 1.013–1.077, P = 0.0052), and language (aOR 1.049, 95% CI 1.013–1.086, P = 0.0072). However, no significant associations were observed between neonatal jaundice and abnormal results in the overall assessment, fine motor, social skills, or self-help domains. Table 2Associations between neonatal jaundice requiring phototherapy and the abnormal K-DST results a in the neurodevelopmental screening b at 66 to 71 months of ageDomains of developmental screeningControl group, n (%)Jaundice group, n (%)cOR(estimate, 95% CI) cP valueaOR c(estimate, 95% CI)P valueOverall assessment14,865/883,019 (1.68%)2,822/121,366 (2.33%)1.390 (1.335–1.448)< 0.0001*1.046 (0.997–1.098)0.0635Gross motor27,761/757,626 (3.66%)4,780/104,010 (4.60%)1.267 (1.228–1.307)< 0.0001*1.087 (1.049–1.127)< 0.0001*Fine motor27,623/757,626 (3.65%)4,675/104,008 (4.49%)1.244 (1.205–1.284)< 0.0001*1.003 (0.967–1.040)0.8743Cognition40,471/757,638 (5.34%)6,595/104,014 (6.34%)1.200 (1.168–1.232)< 0.0001*1.045 (1.013–1.077)0.0052*Language30,408/757,709 (4.01%)5,175/104,022 (4.97%)1.252 (1.215–1.291)< 0.0001*1.049 (1.013–1.086)0.0072*Social skills26,595/757,707 (3.51%)4,313/104,019 (4.15%)1.160 (1.123-1.200)< 0.0001*1.009 (0.972–1.048)0.6286Self-help31,029/757,715 (4.10%)4,984/104,019 (4.79%)1.179 (1.143–1.215)< 0.0001*1.016 (0.981–1.052)0.3728Abbreviations: n Number, K-DST Korean developmental screening test, cOR Crude odd ratio, aOR Adjusted odd ratio, CI Confidence interval* indicated P < 0.05a The neurodevelopmental screening results were categorized into advanced development, age appropriate, follow-up requests, and further evaluation recommendation. Follow-up requests, and further evaluation were considered abnormalb Acquired from the Korean developmental screening test of the National Health Screening Program for Infants and Children, which is conducted between 66 and 71 monthsc Adjusted by sex, birth weight, prematurity, past history of care in the neonatal intensive care units, chromosomal abnormalities, congenital malformations, region at birth, familial income quantiles, calender years at birth, and infant feeding type Table 2Associations between neonatal jaundice requiring phototherapy and the abnormal K-DST results a in the neurodevelopmental screening b at 66 to 71 months of ageDomains of developmental screeningControl group, n (%)Jaundice group, n (%)cOR(estimate, 95% CI) cP valueaOR c(estimate, 95% CI)P valueOverall assessment14,865/883,019 (1.68%)2,822/121,366 (2.33%)1.390 (1.335–1.448)< 0.0001*1.046 (0.997–1.098)0.0635Gross motor27,761/757,626 (3.66%)4,780/104,010 (4.60%)1.267 (1.228–1.307)< 0.0001*1.087 (1.049–1.127)< 0.0001*Fine motor27,623/757,626 (3.65%)4,675/104,008 (4.49%)1.244 (1.205–1.284)< 0.0001*1.003 (0.967–1.040)0.8743Cognition40,471/757,638 (5.34%)6,595/104,014 (6.34%)1.200 (1.168–1.232)< 0.0001*1.045 (1.013–1.077)0.0052*Language30,408/757,709 (4.01%)5,175/104,022 (4.97%)1.252 (1.215–1.291)< 0.0001*1.049 (1.013–1.086)0.0072*Social skills26,595/757,707 (3.51%)4,313/104,019 (4.15%)1.160 (1.123-1.200)< 0.0001*1.009 (0.972–1.048)0.6286Self-help31,029/757,715 (4.10%)4,984/104,019 (4.79%)1.179 (1.143–1.215)< 0.0001*1.016 (0.981–1.052)0.3728Abbreviations: n Number, K-DST Korean developmental screening test, cOR Crude odd ratio, aOR Adjusted odd ratio, CI Confidence interval* indicated P < 0.05a The neurodevelopmental screening results were categorized into advanced development, age appropriate, follow-up requests, and further evaluation recommendation. Follow-up requests, and further evaluation were considered abnormalb Acquired from the Korean developmental screening test of the National Health Screening Program for Infants and Children, which is conducted between 66 and 71 monthsc Adjusted by sex, birth weight, prematurity, past history of care in the neonatal intensive care units, chromosomal abnormalities, congenital malformations, region at birth, familial income quantiles, calender years at birth, and infant feeding type Associations between neonatal jaundice requiring phototherapy and the abnormal K-DST results a in the neurodevelopmental screening b at 66 to 71 months of age Abbreviations: n Number, K-DST Korean developmental screening test, cOR Crude odd ratio, aOR Adjusted odd ratio, CI Confidence interval * indicated P < 0.05 a The neurodevelopmental screening results were categorized into advanced development, age appropriate, follow-up requests, and further evaluation recommendation. Follow-up requests, and further evaluation were considered abnormal b Acquired from the Korean developmental screening test of the National Health Screening Program for Infants and Children, which is conducted between 66 and 71 months c Adjusted by sex, birth weight, prematurity, past history of care in the neonatal intensive care units, chromosomal abnormalities, congenital malformations, region at birth, familial income quantiles, calender years at birth, and infant feeding type Neurodevelopment and neonatal jaundice, stratified by phototherapy duration The median phototherapy duration in the neonatal jaundice group was 3 days (standardized deviation [SD] 2.411), and the first and third quartiles of phototherapy duration were 2, and 4 days, respectively (Supplementary eTable 1). The association between neonatal jaundice and abnormal K-DST results in the NHISC at 66 to 71 months of age, stratified by phototherapy duration, was illustrated in the forest plot presented in Table 3, with additional data available in Supplementary eTable 5. Table 3A forest plot for the associations between neonatal jaundice and the abnormal K-DST results a in national health screeningb at 66 to 71 months of age, stratified by phototherapy durationaORs were adjusted by sex, birth weight, prematurity, past history of care in the neonatal intensive care units, chromosomal abnormalities, congenital malformations, region at birth, familial income quantiles, calender years at birth, and infant feeding typeAbbreviations: K-DST Korean developmental screening test in the national health screening program for infants and children, No Number, aOR Adjusted odd ratio, CI Confidence interval* indicated P < 0.05a The neurodevelopmental screening results were categorized into advanced development, age appropriate, follow-up requests, and further evaluation recommendation. Follow-up requests, and further evaluation were considered as abnormalb Acquired from the Korean developmental screening test of the National Health Screening Program for Infants and Children, which is conducted between 66 and 71 months Table 3A forest plot for the associations between neonatal jaundice and the abnormal K-DST results a in national health screeningb at 66 to 71 months of age, stratified by phototherapy durationaORs were adjusted by sex, birth weight, prematurity, past history of care in the neonatal intensive care units, chromosomal abnormalities, congenital malformations, region at birth, familial income quantiles, calender years at birth, and infant feeding typeAbbreviations: K-DST Korean developmental screening test in the national health screening program for infants and children, No Number, aOR Adjusted odd ratio, CI Confidence interval* indicated P < 0.05a The neurodevelopmental screening results were categorized into advanced development, age appropriate, follow-up requests, and further evaluation recommendation. Follow-up requests, and further evaluation were considered as abnormalb Acquired from the Korean developmental screening test of the National Health Screening Program for Infants and Children, which is conducted between 66 and 71 months A forest plot for the associations between neonatal jaundice and the abnormal K-DST results a in national health screeningb at 66 to 71 months of age, stratified by phototherapy duration aORs were adjusted by sex, birth weight, prematurity, past history of care in the neonatal intensive care units, chromosomal abnormalities, congenital malformations, region at birth, familial income quantiles, calender years at birth, and infant feeding type Abbreviations: K-DST Korean developmental screening test in the national health screening program for infants and children, No Number, aOR Adjusted odd ratio, CI Confidence interval * indicated P < 0.05 a The neurodevelopmental screening results were categorized into advanced development, age appropriate, follow-up requests, and further evaluation recommendation. Follow-up requests, and further evaluation were considered as abnormal b Acquired from the Korean developmental screening test of the National Health Screening Program for Infants and Children, which is conducted between 66 and 71 months Notably, neonates in the fourth quartile (≥ 75th percentile) for phototherapy duration (≥ 5 days) was found to be significantly associated with abnormal neurodevelopmental screening results in the overall assessment (aOR 1.145, 95% CI 1.056–1.241, P = 0.0037), as well as in the gross motor (aOR 1.153, 95% CI 1.082–1.229, P = 0.0026), fine motor (aOR 1.081, 95% CI 1.014–1.152, P = 0.0061), cognition (aOR 1.099, 95% CI 1.040–1.161, P = 0.0084), and language domains (aOR 1.125, 95% CI 1.059–1.195, P = 0.0014). However, no significant associations were observed between neonatal jaundice with phototherapy duration in the first to third quartiles and abnormal results in any neurodevelopmental screening domains. Factors associated with neurodevelopment and neonatal jaundice Factors associated with neonatal jaundice and the abnormal results in the overall assessment of the neurodevelopmental screening at 66 to 71 months of age were analyzed according to the phototherapy duration (Table 4). Low birth weight (< 2.5 kg) was identified as a significant covariate associated between jaundice neonates in both the interquartile range (≥ 25th percentile, < 75th percentile) and highest quartile (≥ 75th percentile) of phototherapy duration and abnormal neurodevelopmental screening results in the overall assessment. Prematurity, and a history of care in the NICU, chromosomal abnormalities, or congenital malformations were also associated covariates between jaundice neonates in the all quartiles for phototherapy duration and abnormal neurodevelopmental screening results in the overall assessment. Furthermore, familial income quntile was a significant associated covariate between the neonates in the highest quartile (≥ 75th percentile) for phototherapy duration and abnormal neurodevelopmental screening results in the overall assessment. However, covariates, such as region at birth, calender year at birth, and infant feeding type were not significantly associated between neonatal jaundice in the all quartiles for phototherapy duration and abnormal neurodevelopmental screening results in the overall assessment. Table 4Factors associated with neonatal jaundice and the abnormal resultsa in the overall assessment domain of the neurodevelopmental screeningb at 66 to 71 months of age according to the phototherapy durationCharacterisctics/Phototherapy durationControl group,n (%)prevalanceJaundice group,n (%)prevalanceEstimateaOR c(estimate, 95% CI) cP valueTotal participants14,865/883,0190.0172822/121,3660.023Sex aBoy9,566/439,8120.022Girl5,299/443,2070.012<25PBoy480/18,8560.025-1.99940.972 (0.879–1.074)0.0265*Girl269/15,8270.017-2.67281.129 (0.990–1.289)25P to 75PBoy819/31,5110.026-1.98831.006 (0.929–1.089)0.6136Girl360/25,0440.014-2.72110.930 (0.826–1.048)≥75PBoy629/17,5600.036-1.95831.136 (1.025–1.260)0.8157Girl265/12,5680.021-2.69611.051 (0.901–1.228)Low birth weight a< 2.5 kg792/26,8990.029≥ 2.5 kg14,073/856,1200.016<25P< 2.5 kg137/4,1980.033-2.17340.930 (0.756–1.143)0.0568≥ 2.5 kg612/30,4850.020-2.47411.042 (0.956–1.136)25P to 75P< 2.5 kg206/6,8430.030-2.20910.833 (0.696–0.996)0.0026*≥ 2.5 kg973/49,7120.020-2.46141.007 (0.939–1.081)≥75P< 2.5 kg340/8,8990.038-2.20050.976 (0.816–1.167)< 0.0001*≥ 2.5 kg554/21,2290.026-2.39921.181 (1.072-1.300)Prematurity aNo14,135/855,7930.017Yes730/27,1860.027<25PNo607/29,6410.020-2.32691.060 (0.972–1.156)0.0110*Yes142/5,0400.028-2.31150.870 (0.711–1.064)25P to 75PNo921/47,5270.019-2.33861.010 (0.940–1.085)0.0157*Yes258/9,0270.029-2.31720.851 (0.723–1.001)≥75PNo512/19,2710.027-2.23021.232 (1.116–1.358)< 0.0001*Yes382/10,8570.035-2.35960.903 (0.765–1.066)Past history of care in the NICU, Chromosomal abnormalities d, or Congenital malformations eNo14,359/868,3350.017Yes506/14,6840.034<25PNo561/28,7000.020-2.50391.063 (0.974–1.161)0.0361*Yes188/5,9830.031-2.20410.912 (0.0760-1.094)25P to 75PNo845/453,6680.002-2.50601.014 (0.954–1.090)0.0296*Yes334/11,1870.030-2.19260.891 (0.767–1.035)≥75PNo406/17,7230.023-2.44631.179 (1.062–1.309)0.0212*Yes488/12,4020.039-2.17611.079 (0.320–1.250)Region at birth bSeoul, metropolitan6,166/390,0660.016City, rural8,524/485,3680.018<25PSeoul, metropolitan289/14,3000.020-2.41151.009 (0.889–1.144)0.9856City, rural447/20,1320.022-2.34371.028 (0.927–1.139)25P to 75PSeoul, metropolitan482/24,1130.020-2.37731.009 (0.912–1.117)0.3389City, rural686/32,0240.021-2.37180.962 (0.882–1.049)≥75PSeoul, metropolitan372/12,7430.029-2.38071.091 (0.953–1.248)0.5964City, rural512/17,1480.030-2.32551.120 (1.002–1.251)Familial income quantile b, fLow (< 25P)4,587/212,7180.022High (≥ 75P)3,111/212,7490.015<25PLow (< 25P)195/7,5840.026-2.11820.934 (0.800-1.091)0.4481High (≥ 75P)180/9,3200.019-2.49731.063 (0.905–1.247)25P to 75PLow (< 25P)327/13,8420.024-2.13470.869 (0.768–0.983)0.0577High (≥ 75P)253/13,2900.019-2.47991.013 (0.880–1.167)≥75PLow (< 25P)254/7,7820.033-2.11890.925 (0.789–1.084)0.0307*High (≥ 75P)171/6,5980.026-2.47591.077 (0.889–1.303)Calender year at birth a2009–20113,806/285,6230.0132012–201511,059/597,3960.019<25P2009–2011144/9,2070.016-2.49780.930 (0.754–1.083)0.39642012–2015605/25,4760.024-2.17511.056 (0.966–1.154)25P to 75P2009–2011270/18,0640.015-2.46190.844 (0.735–0.968)0.13602012–2015909/38,4910.024-2.18851.027 (0.953–1.107)≥75P2009–2011245/10,5680.023-2.47421.026 (0.868–1.212)0.90792012–2015649/19,5600.033-2.15601.132 (1.024–1.251)Infant feeding type aExclusive breast4,451/333,1980.013Mixed, artificial milk10,414/549,8210.019<25PExclusive breast194/11,8390.016-2.51651.005 (0.860–1.173)0.9513Mixed, artificial milk555/22,8440.024-2.24501.026 (0.935–1.126)25P to 75PExclusive breast315/20,4670.015-2.53230.954 (0.842–1.082)0.5398Mixed, artificial milk864/36,0880.024-2.24840.992 (0.910–1.072)≥75PExclusive breast205/9,9090.021-2.51041.085 (0.917–1.284)0.9301Mixed, artificial milk689/20,2190.034-2.22111.113 (1.007–1.229)Abbreviations: n Number, SD Standard deviation, NHSPIC National Health Screening Program for Infants and Children, P Percentile, NICU Neonate intensive care unit* indicated P